TTS 2026 - Meet the Plenary Speakers

John J. Fung
President's Plenary
Presidential Address
Haibo Wang
President's Plenary
President's Guest Speaker
Maria Grazia Roncarolo
PLENARY #1
Gene and cell therapy in transplantation
Ton J. Rabellink
Plenary #3
Vascularized kidney organoids for renal regeneration
Olivia Smibert
Closing Plenary
Microbiome signatures as predictors of post-transplant complications

Plenary Session 2: Panel on Making Xeno Work for Humanity!

Tatsuo Kawai
Clinical Xeno: Experience to date
Anoma Nellore
Xenozoonosis, No Worries!
Richard N. Pierson III
Let’s start with hearts!
Wayne J. Hawthorne
Let’s start with islets!
Luz Padilla
Ethics of New Technology in xenotransplantation

Abstract Submission is now open!

Submission deadline: March 19, 2026 @ 23:59 EST

TTS 2026 is planning on accommodating up to 1,000 Oral Presentations!

Apply for an Award!

Many awards for members tied to an abstract submission

Just Released - Transplantation Direct - February 2026

The February issue of Transplantation Direct covers a full spectrum of topics in transplantation. We feature a several articles in kidney transplantation including an investigation into carboxypeptidase polymorphism associations with allograft loss, a report on the longer-term effects of delayed graft function in recipients, outcomes with combined anti-CD20 and anti-CD38 therapy in regard to FSGS recurrence after transplantation, insight into marked variations in center-specific acceptance of suboptimal donor kidney offers, testing the impact of early elevations in dd-cfDNA on long-term transplant outcomes, and a report on the suitability of wearable digital health devices in older transplant candidates. In liver transplantation, we have a study reporting on predictions of tolerance using microRNA profiling in pediatric transplant recipients. We also spotlight articles in the field of lung transplantation, including results from a prospective study to use dd-cfDNA measurements in lieu of transbronchial biopsies in the first post-transplant year, testing von Willebrand factor in lung microvascular endothelial cells as a surrogate for improving pre-transplant organ conditioning, and an evaluation of variability in clinical lung transplant practices in Canada. For the heart transplant community, we have an article on detection of peripheral blood transcriptomic signatures that identify rejection. On other topics, another article focuses on the importance of MHC matching in pigs with regard to inducing tolerance to VCA transplants after hematopoietic stem cell transplantation. We also have a pig model study on the use of hypothermic machine perfusion to improve pancreas preservation before transplantation. And, finally, for the hematologists, we have a report on the evaluation of intensified treosulfan – fludarabine conditioning with thiotepa addition in older or comorbid patients that have an active myeloid neoplasm undergoing allo-stem cell transplantation. We welcome you to this full slate of articles, which can be accessed in their entirety on our Transplantation Direct website.


Transplantation - Behind the Paper with Satish N. Nadig, Jonathan Bromberg and Anita Chong - February 6, 2026

Federal funding, particularly from the National Institutes of Health, plays a crucial role in advancing transplantation research. This support has helped lay the groundwork for significant progress in understanding transplantation and alloimmunity. The study highlights the achievements made possible through federal dollars, emphasizing the transformation of innovative ideas into clinical applications. However, it also points out the ongoing challenges and unmet needs in the field, suggesting that continued investment is essential for further breakthroughs and improvements in transplantation outcomes.

Call for Nominations Reminder - DEADLINE: FEBRUARY 18, 2026

In 2026, three Officer positions will be vacated and 5 of the 14 Councilors-at-large representing the Regions will be changing. The elections will take place in early 2026 and those elected will assume their new roles starting at the 2026 TTS Congress in Sydney.



Transplantation Journal Highlights

Transplantation Journals - A New Team of Editorial Fellows Has Arrived!

We are thrilled to welcome eleven outstanding new EDITORIAL FELLOWS who officially began their two-year journey with Transplantation and Transplantation Direct in January 2026. This is not just a cohort—it is a truly global community, bringing together voices from Finland, Germany, the UK, the US, India, Brazil, Canada, the Netherlands, Australia, Iran, and Greece.

Spanning career stages from clinicians in training to established professionals, this dynamic group brings deep and diverse expertise across biostatistics, HLA laboratory science, hepatology, cardiology, nephrology, and surgery. Together, they represent the next generation of leaders shaping transplantation science and scholarly publishing.

What will our Editorial Fellows be up to? During their fellowship, they will:

  • Learn from the best through structured mentorship with senior editorial leaders and strategy and progress calls
  • Get hands-on with publishing, reviewing manuscripts, developing editorials and commentaries, evaluating figures, and contributing to editorial decisions
  • Spark creativity by helping develop special thematic sections, central visual figures, and features such as Game Changer and Journal Highlights
  • Amplify impact and outreach via social media, author interviews, webinars, and podcasts

We are incredibly excited to work with this talented and energetic group and look forward to the ideas, insights, and innovations they will bring. The future of transplantation publishing is in excellent hands!

On behalf of the Editorial Team,

Carla Baan
Coordinator of the Editorial Fellowship Program
Transplantation and Transplantation Direct

Stefan Tullius,
Editor-in-Chief
Transplantation and Transplantation Direct

Alvaro Assis de Souza

The Netherlands

Nicole De La Mata

Australia

Ahad Eshraghian

Iran

Maria Florencia Fernandez

United States

Quan Yao Ho

United Kingdom

Emil Holmström

Finland

Jasper Iske

Germany

Sophia Rozani

Greece

Gaurav Tripathi

United States

Kushboo Saxena

India

Arunkumar Subbiah

India

Transplantation Journal - Social Media Content

Professor Jeremy R. Chapman, AC: Editor-in-Chief, The Transplantation Journals
Fadi Issa, DPhil, Nuffield Department of Surgical Sciences, University of Oxford, intreviews Prof. Jeremy Chapman about his lifelong career devoted to transplantation.
Tiling 16S rRNA Gene Amplicon Sequencing Identifies Bacterial Species Soon After Lung Transplant That Predict Acute Cellular Rejection
The lung bacteriome is increasingly recognized as consequential in lung transplant (LTx) outcomes; however, most studies are limited to genus-level taxonomic resolution.

Transplantation Direct - Social Media Content

Early Elevations in Donor-derived Cell-free DNA are Associated With Increased Risk of Future Rejection and Graft Dysfunction After Kidney Transplant
Donor-derived cell-free DNA (dd-cfDNA) is a marker of the presence and severity of injury in kidney transplant recipients (KTRs). The impact of early elevations in dd-cfDNA on long-term outcomes remains unclear.
Combined Anti-CD20/Anti-CD38 Therapy in Posttransplant Focal Segmental Glomerulosclerosis Recurrence: A Retrospective, International, Multicenter Study
Focal segmental glomerulosclerosis (FSGS) recurrence after kidney transplantation is a leading cause of allograft failure and remains difficult to treat. Standard therapies, including plasma exchange (PEX) and rituximab, are often ineffective and poorly tolerated. Growing evidence implicates immune-mediated circulating factors, such as IgG and IgM autoantibodies, in disease pathogenesis. Given the central role of memory B cells and plasma cells in antibody production, we tested the safety/efficacy profile of a combined B-cell and plasma cell–depleting approach with rituximab and daratumumab in patients with posttransplant FSGS recurrence.

Research Grants Program - Now Accepting Notices of Intent

TTS provides funding to individual investigators to support their research in transplantation. The spectrum of studies includes basic, clinical/epidemiological and translational. This individual should have spent five years or less performing research in transplantation (and/or immunology relating to transplant) since obtaining their last doctoral degree (PhD, MD, PharmD, or equivalent). One of these research grants will be preferentially designated to TTS members from a low- or middle-income country. Please send application materials and any questions to jennifer.groverman@tts.org.

Notice of Intent Deadline: March 30, 2026
Full Application Deadline: May 1, 2026

Only applicants who submit a successful Notice of Intent will be eligible to submit a full application.

To further promote equity and global research capacity, the top-ranked applicant from a low- or middle-income country (LMIC) who is not selected for a main Research Grant will be awarded a TTS LMIC Bridge Grant. This program is designed to strengthen proposals for future funding success for researchers in these regions.

As part of this initiative, recipients will also benefit from personalized mentorship through the TTS Research Mentor Program. Each Bridge Grant awardee will be paired with an experienced Senior TTS mentor from an established research program.


International Symposium on Organ Donation and Transplantation in Kyrgyzstan (TDTD 2026)

We are pleased to announce the International Symposium on Organ Donation and Transplantation in Kyrgyzstan (TDTD 2026), which will take place on May 22–23, 2026 in Bishkek. We kindly invite you to submit your scientific abstracts for presentation at the symposium. The abstract submission deadline is March 15, 2026, and submissions should be made via the online system. Further details regarding abstract submission and the symposium are available at www.tdtd2026.com

2026 Women in Transplantation Awards – Nominations Now Open!

Women in Transplantation is delighted to announce that nominations for the Women in Transplantation (WIT) Awards are now open! These awards are presented at the 31st Congress of The Transplantation Society (TTS) on Sept 20-23 in Sydney, Australia.
Nomination packages, including all supporting documents, must be received by May 1st 2026.

DICG & TTS @ WCN 2026 - Yokohama, Japan

Join TTS at WCN 2026 — Discover the sessions we’ll be contributing to and be part of the conversation.
We hope to see you there!


ISN-DICG Joint Session: Organ Trafficking and Transplant Tourism — New Approaches for Prevention

March 30 - 15:50 - 16:50

Mandatory Reporting of Suspicious Cases

Maria Amalia Matamoros

Incentives to Reduce Organ Shortage

Khalida Bulhan - Soki

Addressing Inequities to Prevent Organ Trafficking and Transplant Tourism

Lilia Cervantes

ISN-TTS Joint Session

Maximising Opportunities and Resources in Kidney Transplant Care
March 31 - 09:10 - 10:40

Understanding Gender Disparities in Kidney Transplantation - a Causal Inference Approach

Jessica Harding

Pragmatic Medicine - Learning From the Indian Experience

Shyam Bihari Bansal

Strategies to Help Kidney Transplant Recipients Navigate Through the Complex Medical System Using Patient Navigation

Germaine Wong

Reducing the Environmental Footprint in Transplantation

Ivo Laranjinha

In Case You Missed It...

Transplabtation Journal - February 2026 Editor's Cut

Behind the Paper with Gerald Brandacher


In the News


Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada

Используйте Вавада казино для игры с бонусом — активируйте промокод и начните выигрывать уже сегодня!